NEI Research News

Researchers today are releasing the flagship dataset from an ambitious study of biomarkers and environmental factors that might influence the development of type 2 diabetes, which is associated with a range of eye diseases such as diabetic retinopathy..

Research team has identified advanced preclinical candidates targeting the bisretinoid synthesis pathway, which could help treat macular degeneration and Stargardt disease.

New research suggests long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of shingles-related eye inflammation, infection, and pain.

Too much stuff in the periphery of our vision can make it difficult to identify what we’re seeing. Yale researchers now know how that clutter affects the brain.

New research from the University of Rochester provides important insights into the cellular mechanisms behind AMD and offers potential avenues for new treatments.

A new study reveals how the eye resolves inflammation in the eye disease autoimmune uveitis.

Scientists at the National Eye Institute and their colleagues have identified a gene responsible for some inherited retinal diseases (IRDs), which are a group of disorders that damage the eye’s light-sensing retina and threatens vision.

Each year, the Institute for Scientific Information selects a list of Nobel-class scientists based on journal citation volume.

New research from UChicago shows that the superior colliculus, a brain region that controls eye movements, also plays an important role in higher cognitive functions like categorization and decision making.

Researchers at the National Eye Institute and their collaborators have identified a protein, known as RNF114, that reverses cataracts, a clouding of the eye’s lens that occurs commonly in people as they age.